Submit Deal

INSILICO MEDICINE

HQ - Boston

Summary

Insilico Medicine is a clinical-stage, AI-driven drug discovery company.

Deals Overview

Total Deals4

Valued Deals4

Total Value£ 351 M

Avg. Deal Size£ 88 M

Market Context

Senior Management

Alex Zhavoronkov
Founder and Co-CEO
Feng Ren
Chief Scientific Officer and Co-CEO

Sort

22 Jun 2021|Hong Kong|Biotechnology

Target: INSILICO MEDICINE

Bidder: FORMICA CAPITAL

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 183 M

Value

06 Jun 2022|Hong Kong|Biotechnology

Target: INSILICO MEDICINE

Bidder: WARBURG PINCUS LLC

8 Service Providers

2 Target | 6 Bidder

17 Dealmakers

11 Target | 6 Bidder

£ 48 M

Value

10 Aug 2022|Hong Kong|Biotechnology

Target: INSILICO MEDICINE

Bidder: SAUDI ARAMCO ENERGY VENTURES

5 Service Providers

2 Target | 3 Bidder

11 Dealmakers

7 Target | 4 Bidder

£ 28 M

Value

13 Mar 2025|United States|Biotechnology

Target: INSILICO MEDICINE

Bidder: VALUE PARTNERS GROUP

2 Service Providers

1 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 90 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Alex Zhavoronkov
Founder and Co-CEO
Feng Ren
Chief Scientific Officer and Co-CEO